Comparison of the Antiviral Activities of Alkoxyalkyl and Alkyl Esters of Cidofovir against Human and Murine Cytomegalovirus Replication In Vitro
Open Access
- 1 February 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (2) , 656-662
- https://doi.org/10.1128/aac.49.2.656-662.2005
Abstract
Alkoxyalkyl esters of cidofovir (CDV) have substantially greater antiviral activity and selectivity than unmodified CDV against herpesviruses and orthopoxviruses in vitro. Enhancement of antiviral activity was also noted when cyclic CDV was esterified with alkoxyalkanols. In vitro antiviral activity of the most active analogs against human cytomegalovirus (HCMV) and orthopoxviruses was increased relative to CDV up to 1,000- or 200-fold, respectively. Alkyl chain length and linker structure are important potential modifiers of antiviral activity and selectivity. In this study, we synthesized a series of alkoxyalkyl esters of CDV or cyclic CDV with alkyl chains from 8 to 24 atoms and having linker moieties of glycerol, propanediol, and ethanediol. We also synthesized alkyl esters of CDV which lack the linker to determine if the alkoxyalkyl linker moiety is required for activity. The new compounds were evaluated in vitro against HCMV and murine CMV (MCMV). CDV or cyclic CDV analogs both with and without linker moieties were highly active against HCMV and MCMV, and their activities were strongly dependent on chain length. The most active compounds had 20 atoms esterified to the phosphonate of CDV. Both alkoxypropyl and alkyl esters of CDV provided enhanced antiviral activities against CMV in vitro. Thus, the oxypropyl linker moiety is not required for enhanced activity. CDV analogs having alkyl ethers linked to glycerol or ethanediol linker groups also demonstrated increased activity against CMV.Keywords
This publication has 21 references indexed in Scilit:
- Ether Lipid‐Ester Prodrugs of Acyclic Nucleoside Phosphonates: Activity against Adenovirus Replication In VitroThe Journal of Infectious Diseases, 2005
- Oral Treatment of Murine Cytomegalovirus Infections with Ether Lipid Esters of CidofovirAntimicrobial Agents and Chemotherapy, 2004
- Design and development of oral drugs for the prophylaxis and treatment of smallpox infectionTrends in Biotechnology, 2004
- Inhibitory Activity of Alkoxyalkyl and Alkyl Esters of Cidofovir and Cyclic Cidofovir against Orthopoxvirus Replication In VitroAntimicrobial Agents and Chemotherapy, 2004
- Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of CidofovirAntimicrobial Agents and Chemotherapy, 2004
- Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus InfectionsClinical Microbiology Reviews, 2003
- Transbilayer Movement of Dipalmitoylphosphatidylcholine in Proteoliposomes Reconstituted from Detergent Extracts of Endoplasmic ReticulumPublished by Elsevier ,2002
- Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic CidofovirAntimicrobial Agents and Chemotherapy, 2002
- Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and AdefovirClinical Pharmacokinetics, 1999
- CidofovirDrugs, 1999